Journal of Psychiatric Research

Epidemiology of hospitalizations with cocaine use disorder: A 17-year U.S. national study.  144:32-36. 2021

Letter to the editor: Cocaine use and cocaine use disorder: Revisiting epidemiology and clinical impact: Cocaine use disorder hospitalization burden, time-trends and outcomes.  143:467-468. 2021

Yoga is effective in treating symptoms of Gulf War illness: A randomized clinical trial.  143:563-571. 2021

Illness stage and predominant polarity in bipolar disorder: Correlation with burden of illness and moderation of treatment outcome.  140:205-213. 2021

Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression.  140:350-356. 2021

Predicting suicidal behavior and self-harm after general hospitalization of adults with serious mental illness.  136:515-521. 2021

Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.  117:108-115. 2019

Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care – The reality of treatment resistant-based therapies.  114:211-213. 2019

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.  111:59-67. 2019

A randomized controlled trial comparing a “bottom-up” and “top-down” approach to cognitive training in schizophrenia.  109:118-125. 2019

A latent class analysis of PTSD symptoms among inner city primary care patients.  98:1-8. 2018

Correcting delayed circadian phase with bright light therapy predicts improvement in ADHD symptoms: A pilot study.  91:105-110. 2017

Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms.  91:169-176. 2017

DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation.  89:115-124. 2017

Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ).  89:48-54. 2017

The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression.  82:58-67. 2016

Evidence for alterations of the glial syncytial function in major depressive disorder.  72:15-21. 2016

The pro-inflammatory profile of depressed patients is (partly) related to obesity.  70:91-97. 2015

Structure and correlates of self-reported empathy in schizophrenia.  66-67:60-66. 2015

Exploring facial emotion perception in schizophrenia using transcranial magnetic stimulation and spatial filtering.  58:102-108. 2014

Impairment in local and global processing and set-shifting in body dysmorphic disorder.  57:41-50. 2014

Toll-like receptors in the depressed and suicide brain.  53:62-68. 2014

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex.  47:1215-1221. 2013

Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder.  47:307-314. 2013

Glutamate transporters: A key piece in the glutamate puzzle of major depressive disorder.  47:1150-1156. 2013

Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease.  47:1187-1191. 2013

Oxidative stress and glutathione response in tissue cultures from persons with major depression.  46:1326-1332. 2012

Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.  46:57-63. 2012

Efficacy and specificity of Social Cognitive Skills Training for outpatients with psychotic disorders.  45:1113-1122. 2011

Childhood trauma history differentiates amygdala response to sad faces within MDD.  45:886-895. 2011

Glycogen synthase kinase-3β in the platelets of patients with mood disorders: Effect of treatment.  44:143-148. 2010

Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia.  44:499-505. 2010

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.  43:247-254. 2009

Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: Effect of treatment with mood stabilizing drugs.  42:106-116. 2008

Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia.  42:1076-1085. 2008

Presenting characteristics of depressed outpatients as a function of recurrence: Preliminary findings from the STAR*D clinical trial.  40:59-69. 2006

Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression.  37:421-432. 2003

The role of life events in onset and recurrent episodes of schizophrenia and schizoaffective disorder.  32:283-288. 1998

Editorial.  31:157-158. 1997

Absence of ketamine effects on memory and other cognitive functions in schizophrenic patients.  30:321-330. 1996

Frequency of neuropathology in a brain bank from a long-term, domiciliary population.  30:45-49. 1996